先进的纳米药物用于治疗耐火性炎症相关疾病
Xiuxiu Wang1, Xinran Song2, Wei Feng2
1Naval Medical Center of PLA, Naval Medical University, Shanghai, 200052, People's Republic of China.
Nano-micro letters
|July 6, 2025
概括
纳米医学提供了一种有前途的方法,通过向炎症途径和细胞因子来对抗慢性炎症. 本综述分析了纳米材料设计,应用和在炎症性疾病中临床转化方面的挑战.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症是对各种压力因素的防御机制,但如果失调,可能导致慢性疾病.
- 反应性氧物种 (ROS) 和促炎性细胞因子是炎症相关病理的关键调解者.
- 纳米医学利用纳米技术来抑制炎症信号通路并解决炎症.
研究的目的:
- 审查纳米医学的当前进展,以治疗与炎症相关的病理.
- 分析纳米材料设计,合成和毒性,用于临床转化.
- 突出功能纳米材料在耐火炎症条件中的应用.
主要方法:
- 对纳米材料设计和合成当前进展的系统分析.
- 讨论纳米材料的毒性机制,影响因素和评估方法.
- 对纳米医学在伤口愈合,胃肠道,免疫,神经和循环系统疾病中的应用进行了审查.
主要成果:
- 纳米医学有效地抑制炎症信号通路和促炎细胞因子.
- 功能性纳米材料在治疗各种炎症疾病方面显示出潜力.
- 关键的挑战包括优化生物相容性,生物分布控制和毒性评估.
结论:
- 纳米医学对与炎症相关的疾病具有显著的治疗潜力.
- 解决生物相容性,生物分布和毒性方面的挑战对于临床翻译至关重要.
- 将材料创新与治疗疗效相结合,对于推进纳米医学至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
238
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
238
Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275
Drugs for Treatment of Ulcerative Colitis in IBD
242
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
242
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
208
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
208
Microorganisms in Medicine and Therapeutics
349
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
349


